AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease.
about
Micro-RNA-195 and -451 regulate the LKB1/AMPK signaling axis by targeting MO25The signaling involving in autophagy machinery in keratinocytes and therapeutic approaches for skin diseasesTargeting myocardial substrate metabolism in heart failure: potential for new therapiesThe role of Fatty Acid oxidation in the metabolic reprograming of activated t-cellsCellular and molecular biology of aging endothelial cellsThiopental inhibits global protein synthesis by repression of eukaryotic elongation factor 2 and protects from hypoxic neuronal cell deathProgress of small molecular inhibitors in the development of anti-influenza virus agents.Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes.To eat or not to eat: the effect of AICAR on food intake regulation in yellow-bellied marmots (Marmota flaviventris)A single nucleotide polymorphism in STK11 influences insulin sensitivity and metformin efficacy in hyperinsulinemic girls with androgen excess.Anti-inflammatory nutrition as a pharmacological approach to treat obesityProtection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198).Regulation of AMPK by the ubiquitin proteasome systemGrape polyphenols inhibit Akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancer.Three 4-letter words of hypertension-related cardiac hypertrophy: TRPC, mTOR, and HDAC.Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathwaysMetformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosisPost-treatment with the combination of 5-aminoimidazole-4-carboxyamide ribonucleoside and carnitine improves renal function after ischemia/reperfusion injuryMetformin inhibits nuclear receptor TR4-mediated hepatic stearoyl-CoA desaturase 1 gene expression with altered insulin sensitivity.Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection?AMPK enhances insulin-stimulated GLUT4 regulation via lowering membrane cholesterol.The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese.Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysisInsulin down-regulates the expression of ubiquitin E3 ligases partially by inhibiting the activity and expression of AMP-activated protein kinase in L6 myotubes.Oestrogen receptors interact with the α-catalytic subunit of AMP-activated protein kinase.Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease.Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of β-catenin.A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats.Metabolic switching and fuel choice during T-cell differentiation and memory development.Insulin resistance: metabolic mechanisms and consequences in the heart.CHIP protects against cardiac pressure overload through regulation of AMPK.AICAR reduces the collagen-stimulated secretion of PDGF-AB and release of soluble CD40 ligand from human platelets: Suppression of HSP27 phosphorylation via p44/p42 MAP kinase.The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.Interactome analysis of AMP-activated protein kinase (AMPK)-α1 and -β1 in INS-1 pancreatic beta-cells by affinity purification-mass spectrometry.AMP-activated protein kinase: a stress-responsive kinase with implications for cardiovascular disease.Pharmacological treatment of obesity in children and adolescents: current status and perspectives.Physical activity as the main therapeutic tool for metabolic syndrome in childhood.AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan.Nitric oxide: orchestrator of endothelium-dependent responses.AMPK - Activated Protein Kinase and its Role in Energy Metabolism of the Heart.
P2860
Q21134128-AFE4F775-89A1-457A-861D-49D0266B839DQ26748610-A967C4CF-AAD1-4C72-AD7E-922B20C2A2D8Q27694733-6AB99A10-DD96-4F79-9F6A-C9BA96E78FA0Q28080686-8E83B338-8E15-41F5-BA40-FED87711EA59Q28081013-AA352BF6-220F-46DE-993F-F2A64A8A13B7Q28534586-B7AE17BE-6A53-4745-A5D4-D0E6916C6DE0Q30234943-69EC6EA1-5583-4831-8FFE-9751870F16C3Q33793434-3C534F1A-F47C-43F1-AC98-ECAD4209A3A4Q33884299-4317C6B6-3FC6-47CB-8BFA-C291204D8BB8Q33932744-8C8A353F-FBD0-48FF-B561-D5F1057EE4CAQ34189477-93E7EB8E-C17D-4249-9ABC-FE7DEB961377Q34214717-F49AC410-3D3D-4394-AB5D-8FC90FF02CD6Q34756301-8C82D84C-1AFF-4FED-AC4E-8339F2DAD0FDQ34855692-525149C4-52FC-4A12-82C9-C249938ECD35Q34969926-6FF5FC37-89DA-4154-9ECB-7DDBD0AEE66DQ34998025-9325D8F3-F254-41D6-BDF5-F71F7BBBEABEQ35114963-0A527CC9-69BE-43BD-8F98-0855DF96BD31Q35613008-5CDFA634-D1A4-473A-85E0-36DB30F72E58Q35796984-2C66F016-F721-46FF-9033-1FE2211877A0Q35838049-DE54B3B1-F05A-4676-8B61-532EDC022C49Q35920708-B339D6E5-7415-41B2-992A-08D6A644144BQ36031170-879B478C-B5E0-482D-A9E7-83B562D25F60Q36051510-3A2BBB0A-849D-4646-9B8B-27A5667BC606Q36185141-88CFE41B-6116-4DB6-A0CD-9C3B99064E4AQ36227345-F6542EE5-388C-4632-904E-5DEEC2D8A916Q36251554-4CE66A90-9F12-4CCB-AC77-AC99A59F5B1BQ36329814-10FFC602-F896-4D29-9174-6F792FDA5AE4Q36815297-B41DA911-310A-4A6E-9230-96EA86833FA3Q36820974-399F81AB-E132-4A31-8747-B0383A746BE0Q36821424-5392113A-8E60-4A76-A3DA-3E360A1A75EAQ37052961-8D24A943-D9B0-4A8E-9F42-DFE733FF736BQ37108786-84974D40-E1CD-4A92-A23F-4164394FEBFEQ37400658-6FB632E4-68EF-49D5-A1F3-702FBEA3C1CAQ37636514-83C910C3-C249-44C8-A4F9-4287162EFDB9Q37671250-741FA81C-CABC-4EDE-B29A-1C1AE8FCC459Q37801370-2F2ED312-7616-47A6-8338-1C8CA1682FD9Q37817710-C7673352-2A22-41B4-9C36-3FD751E1269EQ37856788-8B663E6A-0BF7-4503-9EED-69FE7574BFA8Q37927098-F5D12C4A-BA20-4AF7-9625-BC6956303DB4Q37951443-92F4C772-10D8-45DF-98F4-468DB99467EB
P2860
AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
AMP-activated protein kinase p ...... et in cardiometabolic disease.
@en
AMP-activated protein kinase p ...... et in cardiometabolic disease.
@nl
type
label
AMP-activated protein kinase p ...... et in cardiometabolic disease.
@en
AMP-activated protein kinase p ...... et in cardiometabolic disease.
@nl
prefLabel
AMP-activated protein kinase p ...... et in cardiometabolic disease.
@en
AMP-activated protein kinase p ...... et in cardiometabolic disease.
@nl
P2093
P2860
P921
P356
P1433
P1476
AMP-activated protein kinase p ...... et in cardiometabolic disease.
@en
P2093
Aaron K F Wong
Chim C Lang
Jacqueline Howie
John R Petrie
P275
P2860
P304
P356
10.1042/CS20080066
P407
P5008
P577
2009-04-01T00:00:00Z